Abhimanyu Garg;Simeon I. Taylor;Elif Ariogiu Oral;Alexander M. DePaoli
发明人:
Alexander M. DePaoli,Elif Ariogiu Oral,Simeon I. Taylor,Abhimanyu Garg
申请号：
US13669324
公开号：
US20130190225A1
申请日:
2012.11.05
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Leptin, leptin analogs, and leptin derivatives are used to treat patients with lipoatrophy. Leptin is effective against conditions of lipoatrophy for both genetic and acquired forms of the disease. A therapeutically effective amount of leptin can be administered in a variety of ways, including subcutaneously and using gene therapy methods. Methods of the present invention contemplate administration of leptin, leptin analogs, and leptin derivatives to patients having a leptin level of approximately 4 ng/ml or less before treatment.
